BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9235312)

  • 1. [Neuroleptic malignant syndrome from treatment with antidepressives].
    Heinemann F; Assion HJ; Laux G
    Fortschr Neurol Psychiatr; 1997 May; 65(5):208-13. PubMed ID: 9235312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroleptic malignant syndrome under treatment with antidepressants? A critical review.
    Assion HJ; Heinemann F; Laux G
    Eur Arch Psychiatry Clin Neurosci; 1998; 248(5):231-9. PubMed ID: 9840369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neuroleptic malignant syndrome and atypical antipsychotics: a brief review].
    Khaldi S; Kornreich C; Choubani Z; Gourevitch R
    Encephale; 2008 Dec; 34(6):618-24. PubMed ID: 19081460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pathophysiology and therapy of malignant neuroleptic syndrome].
    Weller M; Kornhuber J
    Nervenarzt; 1992 Nov; 63(11):645-55. PubMed ID: 1361662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroleptic malignant syndrome due to atypical neuroleptics: three episodes in one patient.
    Bottlender R; Jäger M; Hofschuster E; Dobmeier P; Möller HJ
    Pharmacopsychiatry; 2002 May; 35(3):119-21. PubMed ID: 12107858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A study of neuroleptic malignant syndrome in the presenium and senium].
    Suzuki I; Honma H; Watanabe N; Matsubara S; Koyama T
    Seishin Shinkeigaku Zasshi; 1998; 100(6):387-97. PubMed ID: 9745353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Malignant neuroleptic syndrome. A review of epidemiology, risk factors, diagnosis, differential diagnosis and pathogenesis of MNS].
    Andreassen MD; Pedersen S
    Ugeskr Laeger; 2000 Mar; 162(10):1366-70. PubMed ID: 10745673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroleptic malignant syndrome in Mexico.
    Montoya A; Ocampo M; Torres-Ruiz A
    Can J Clin Pharmacol; 2003; 10(3):111-3. PubMed ID: 14506509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical study of neuroleptic malignant syndrome in demented patients--examination of our case and reported cases].
    Kimura T; Yoshida H
    No To Shinkei; 1994 Sep; 46(9):859-62. PubMed ID: 7999444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amisulpride and neuroleptic malignant syndrome.
    Tu MC; Hsiao CC
    Chang Gung Med J; 2011; 34(5):536-40. PubMed ID: 22035899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroleptic malignant syndrome: physiological and laboratory findings in a series of nine cases.
    Harsch HH
    J Clin Psychiatry; 1987 Aug; 48(8):328-33. PubMed ID: 2886491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Malignant neuroleptic syndrome under metoclopramide and neuroleptics in anuria].
    Krähenbühl S; Raisin J; Herren T
    Schweiz Med Wochenschr; 1993 Jul; 123(26):1359-62. PubMed ID: 8342005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clozapine: a neuroleptic at risk of provoking neuroleptic malignant syndrome (NMS) or an alternative neuroleptic with positive NMS case histories?].
    Weller M; Kornhuber J
    Fortschr Neurol Psychiatr; 1993 Jun; 61(6):217-22. PubMed ID: 8330832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical course and CSF monoamine metabolism in neuroleptic malignant syndrome--a study of nine typical cases and five mild cases].
    Nishijima K; Ishiguro T
    Seishin Shinkeigaku Zasshi; 1989; 91(6):429-56. PubMed ID: 2479043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A patient with Parkinson's disease complicated by hypothyroidism who developed malignant syndrome after discontinuation of etizolam].
    Kawajiri M; Ohyagi Y; Furuya H; Araki T; Inoue N; Esaki S; Yamada T; Kira J
    Rinsho Shinkeigaku; 2002 Feb; 42(2):136-9. PubMed ID: 12424963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. General anesthesia after neuroleptic malignant syndrome.
    Lotstra F; Linkowski P; Mendlewicz J
    Biol Psychiatry; 1983 Feb; 18(2):243-7. PubMed ID: 6131703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Two case studies of neuroleptic malignant syndrome].
    Elvira Cruáñez V; Fernández-Villamor Ortiz R; Pérez Hernández R; Carazo Montijano C; Serrano Simón JM
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1991; 19(1):47-51. PubMed ID: 2048442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neuroleptic malignant syndrome. Case reports].
    Berardi D; Troia M; Veronesi L; Ferrari G
    Minerva Psichiatr; 1994 Dec; 35(4):199-219. PubMed ID: 7861943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Torecan-induced neuroleptic malignant syndrome].
    Bulvik S; Shimoni Z; Kaplan CL
    Harefuah; 1990 May; 118(10):576-8. PubMed ID: 2358219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroleptic malignant syndrome or parkinsonism hyperpyrexia syndrome.
    Granner MA; Wooten GF
    Semin Neurol; 1991 Sep; 11(3):228-35. PubMed ID: 1947485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.